Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation

Screening for Preeclampsia

(2017) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Committee Opinion No 700

(2017)   OBSTETRICS AND GYNECOLOGY

Sequential plasma angiogenic factors levels in women with suspected preeclampsia

(2016) Kedak Baltajian et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study

(2016) Steven J. Korzeniewski et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Cell-free DNA fetal fraction and preterm birth

(2016) Lorraine Dugoff et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Elevated Levels of Total Cell-Free DNA in Maternal Serum Samples Arise from the Generation of Neutrophil Extracellular Traps

(2016) Chanchal Sur Chowdhury et al.   FETAL DIAGNOSIS AND THERAPY

Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes

(2016) Florentine F. Thurik et al.   PRENATAL DIAGNOSIS

Measurement of Circulating Cell-Free DNA Levels by a Simple Fluorescent Test in Patients With Breast Cancer

(2015) Ravit Agassi et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cell-free nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists?

(2014) Sinuhe Hahn et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Cell-free fetal DNA and pregnancy-related complications (Review)

(2014) STAVROS SIFAKIS et al.   Molecular Medicine Reports

Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care

(2014) Avital Avriel et al.   PLoS One

Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease

(2013) E.S. Taglauer et al.   PLACENTA

Cell-free fetal DNA and adverse outcome in low risk pregnancies

(2012) Werner Stein et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies

(2012) Yosun Görkem Zeybek et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Circulating cell-free DNA in hemodialysis patients predicts mortality

(2012) D. Tovbin et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics

(2012) G. Ashoor et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Measurement of Circulating Cell-Free DNA Levels by a New Simple Fluorescent Test in Patients With Primary Colorectal Cancer

(2011) David Czeiger et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cell-free Nucleic Acids as Potential Markers for Preeclampsia

(2011) S. Hahn et al.   PLACENTA

Plasma cell-free DNA in ovarian cancer

(2010) Aparna A. Kamat et al.   CANCER

Analysing cell-free plasma DNA and SLE disease activity

(2010) Johanna Atamaniuk et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia

(2010) Giovanna Oggé et al.   Journal of Maternal-Fetal & Neonatal Medicine

Assessment of Cell-Free DNA with Microvascular Complication of Type II Diabetes Mellitus, Using PCR and Elisa

(2010) Shereen A. El Tarhouny et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Detection and Monitoring of Cell-Free DNA in Blood of Patients with Colorectal Cancer

(2009) Heidi Schwarzenbach et al.   Annals of the New York Academy of Sciences

Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia

(2009) Levente Lazar et al.   BMC Medical Genetics

Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth Restriction

(2009) M. Al Nakib et al.   FETAL DIAGNOSIS AND THERAPY

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

(2009) Juan Pedro Kusanovic et al.   Journal of Maternal-Fetal & Neonatal Medicine

Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis

(2009) Ruifeng Zhang et al.   LUNG CANCER

A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids

(2009) H. Goldshtein et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Cell-Free Plasma DNA as a Predictor of Outcome in Severe Sepsis and Septic Shock

(2008) K. Saukkonen et al.   CLINICAL CHEMISTRY

Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2

(2008) Francesca Gotsch et al.   Journal of Maternal-Fetal & Neonatal Medicine

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

(2008) Offer Erez et al.   Journal of Maternal-Fetal & Neonatal Medicine

Non-invasive fetal sex determination: Impact on clinical practice

(2008) Kirstin M. Finning et al.   Seminars in Fetal & Neonatal Medicine